Wellington Shields & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Sell |
16,749
-1,095
| -6% | -$84.4K | 0.31% | 78 |
|
|
2025
Q4 | $1.42M | Sell |
17,844
-1,308
| -7% | -$103K | 0.35% | 66 |
|
|
2025
Q3 | $1.44M | Sell |
19,152
-1,868
| -9% | -$128K | 0.38% | 65 |
|
|
2025
Q2 | $1.45M | Sell |
21,020
-100
| -0.5% | -$6.56K | 0.41% | 64 |
|
|
2025
Q1 | $1.43M | Sell |
21,120
-1,627
| -7% | -$97.4K | 0.45% | 53 |
|
|
2024
Q4 | $1.02M | Sell |
22,747
-5,959
| -21% | -$334K | 0.31% | 80 |
|
|
2024
Q3 | $1.81M | Sell |
28,706
-1,642
| -5% | -$95.8K | 0.55% | 42 |
|
|
2024
Q2 | $1.79M | Sell |
30,348
-1,529
| -5% | -$95.6K | 0.58% | 34 |
|
|
2024
Q1 | $2.54M | Sell |
31,877
-394
| -1% | -$30.1K | 0.85% | 23 |
|
|
2023
Q4 | $2.55M | Sell |
32,271
-2,432
| -7% | -$173K | 0.94% | 23 |
|
|
2023
Q3 | $2.42M | Buy |
34,703
+1,922
| +6% | +$136K | 0.61% | 25 |
|
|
2023
Q2 | $2.27M | Sell |
32,781
-6,351
| -16% | -$452K | 0.53% | 25 |
|
|
2023
Q1 | $2.91M | Sell |
39,132
-1,097
| -3% | -$92K | 0.65% | 18 |
|
|
2022
Q4 | $3.75M | Sell |
40,229
-2,625
| -6% | -$253K | 0.85% | 11 |
|
|
2022
Q3 | $4.09M | Buy |
42,854
+2,472
| +6% | +$245K | 1.78% | 10 |
|
|
2022
Q2 | $3.74M | Sell |
40,382
-3,872
| -9% | -$378K | 0.91% | 11 |
|
|
2022
Q1 | $4.48M | Sell |
44,254
-70
| -0.2% | -$7.35K | 1.47% | 12 |
|
|
2021
Q4 | $4.57M | Buy |
44,324
+2,574
| +6% | +$238K | 0.91% | 12 |
|
|
2021
Q3 | $3.54M | Sell |
41,750
-779
| -2% | -$65.3K | 1.24% | 15 |
|
|
2021
Q2 | $3.55M | Sell |
42,529
-2,160
| -5% | -$177K | 1.17% | 17 |
|
|
2021
Q1 | $3.36M | Sell |
44,689
-3,054
| -6% | -$222K | 1.2% | 15 |
|
|
2020
Q4 | $3.26M | Sell |
47,743
-2,340
| -5% | -$152K | 1.17% | 16 |
|
|
2020
Q3 | $2.92M | Buy |
50,083
+2,333
| +5% | +$145K | 1.23% | 20 |
|
|
2020
Q2 | $3.1M | Sell |
47,750
-600
| -1% | -$37.8K | 1.36% | 14 |
|
|
2020
Q1 | $2.87M | Buy |
48,350
+775
| +2% | +$51.7K | 1.58% | 11 |
|
|
2019
Q4 | $3.53M | Buy |
47,575
+15,925
| +50% | +$1.12M | 1.57% | 13 |
|
|
2019
Q3 | $2M | Sell |
31,650
-4,450
| -12% | -$264K | 3.08% | 3 |
|
|
2019
Q2 | $1.97M | Buy |
36,100
+6,800
| +23% | +$366K | 0.93% | 25 |
|
|
2019
Q1 | $1.58M | Buy |
29,300
+19,882
| +211% | +$1.23M | 0.8% | 35 |
|
|
2018
Q4 | $617K | Buy |
9,418
+3,018
| +47% | +$225K | 0.35% | 79 |
|
|
2018
Q3 | $504K | Buy |
6,400
+700
| +12% | +$50K | 0.27% | 82 |
|
|
2018
Q2 | $367K | Sell |
5,700
-1,400
| -20% | -$92.3K | 0.19% | 98 |
|
|
2018
Q1 | $442K | Sell |
7,100
-200
| -3% | -$14.3K | 0.24% | 91 |
|
|
2017
Q4 | $529K | Buy |
7,300
+600
| +9% | +$43.6K | 0.28% | 82 |
|
|
2017
Q3 | $545K | Buy |
6,700
+200
| +3% | +$15.8K | 0.18% | 73 |
|
|
2017
Q2 | $523K | Sell |
6,500
-200
| -3% | -$15.8K | 0.18% | 68 |
|
|
2017
Q1 | $526K | Sell |
6,700
-500
| -7% | -$39.9K | 0.16% | 61 |
|
|
2016
Q4 | $568K | Buy |
+7,200
| New | +$583K | 0.3% | 59 |
|
|
2015
Q3 | – | Sell |
-1,909
| Closed | -$200K | – | 97 |
|
|
2015
Q2 | $200K | Buy |
+1,909
| New | +$195K | 0.07% | 103 |
|
Other funds holding CVS
VCM
VPM
Wellington Shields & Co's CVS Position: Q1 2026 in Review
Wellington Shields & Co reduced its CVS Health (CVS) stake by 6.1% in Q1 2026, selling an estimated $84.4K and leaving 16,749 shares worth $1.2M. The position accounts for 0.31% of the portfolio, ranked #78.
Wellington Shields & Co first reported a position in CVS in Q2 2015 and has held it in 39 quarters since. The position peaked at $4.57M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Wellington Shields & Co held 16,749 shares of CVS Health worth $1.2M as of Q1 2026.
- Wellington Shields & Co sold 1,095 CVS Health shares in Q1 2026, an estimated $84.4K.
- CVS Health made up 0.31% of Wellington Shields & Co's portfolio in Q1 2026, its #78 holding.
- Wellington Shields & Co first reported a position in CVS Health in Q2 2015 and has held it in 39 quarters since.
- Wellington Shields & Co's CVS Health position peaked at $4.57M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.